You are here: Industry Insights > COVID-19 vaccine

News List

UK provides funding support for Covid-19 vaccine programme pharmaceutical-technology
May 19, 2020
The UK Government has committed to providing £84m in funding and manufacturing support to researchers working on Covid-19 vaccine programme, said Business Secretary Alok Sharma.
Oxford University’s Covid-19 vaccine shows promise in animal study pharmaceutical-technology
May 18, 2020
The University of Oxford in the UK has reported positive findings of its Covid-19 vaccine candidate in a small preclinical study involving six monkeys.
Predictive Oncology joins race to develop Covid-19 vaccine pharmaceutical-technology
May 18, 2020
Predictive Oncology has joined the race to develop a Covid-19 vaccine with the acquisition of Soluble Therapeutics, followed by collaboration and licensing of a new nanoparticle vaccine technology platform.
Vibalogics to Manufacture Clinical Material for Janssen contractpharma
May 15, 2020
CDMO to provide additional clinical trial material for COVID-19 vaccine candidate.
Scientific leaders call for harmonised COVID-19 vaccine R&D europeanpharmaceuticalreview
May 14, 2020
Experts from the US National Institutes of Health have written a commentary to promote a collaborative approach for the testing, scale-up and distribution of COVID-19 vaccine candidates.
FDA fast-tracks Moderna’s Covid-19 vaccine candidate pharmaceutical-technology
May 14, 2020
The US Food and Drug Administration (FDA) has awarded fast-track designation to Moderna mRNA vaccine candidate, mRNA-1273, developed to protect against Covid-19.
TAU and Neovii team up to develop Covid-19 vaccine pharmaceutical-technology
May 14, 2020
Israel-based Tel Aviv University (TAU)’s technology transfer company Ramot has entered a research and licence agreement with Swiss-based biopharmaceutical company Neovii to develop a vaccine against Covid-19.
CEPI invests $384m in Novavax COVID-19 vaccine candidate europeanpharmaceuticalreview
May 13, 2020
CEPI has announced that its funding for the Novavax COVID-19 vaccine candidate will go towards Phase I and Phase II trials as well as manufacturing costs.
Programme to develop sustainable cold chain delivery for COVID-19 vaccine initiated europeanpharmaceuticalreview
May 13, 2020
Researchers have begun research to find how sustainable cold chain delivery systems for a COVID-19 vaccine can be established in resource-poor countries.
CEPI to provide up to $388m for Novavax’s Covid-19 vaccine pharmaceutical-technology
May 13, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has agreed to provide up to $384m in funding to support Novavax in the development and manufacturing of Covid-19 vaccine candidate, NVX-CoV2373.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page